Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Ashley Marton, M.D.C.M., Joins The Eugene M. and Christine E. Lynn Cancer Institute as a Hematologist and Medical Oncologist
Hematologist and medical oncologist Ashley Marton, M.D.C.M., has joined the Eugene M. and Christine E. Lynn Cancer Institute - Boynton Beach, part of Baptist Health Cancer Care
Announce Dr. Ashley Marton’s appointment at the Eugene M. and Christine E. Lynn Cancer Institute in Boynton Beach.
Approach:
Clinical practice: She treats solid tumors and hematologic conditions, with a clinical focus on breast, prostate and colon cancers.
Background: Before joining Baptist Health, she practiced at Hôpital de la Cité-de-la-Santé in Laval, Québec, and was an assistant professor at the University of Montreal. She completed medical school and residencies at McGill University.
Research and care philosophy: She has served as a principal investigator and sub-investigator in oncology trials. Her stated interests include access to therapies through trials, integrating new treatments, medical resource use and artificial intelligence. She describes her care approach a…
Key Findings:
Dr. Marton is certified in internal medicine, hematology and medical oncology by the Royal College of Physicians and Surgeons of Canada.
She is fluent in English and French.
She will see patients at Lynn Cancer Institute, 2623 S. Seacrest Blvd., Suite 60, Boynton Beach, Florida.
Interpretation:
The announcement describes Dr. Marton’s appointment, clinical focus, professional background and research interests.
Limitations:
The provided context does not include a publication date or source URL.
Harold Burstein, MD, PhD, and Laura S. Dominici, MD, FACS, discuss highlights from the SENOMAC trial which sheds light on whether some patients with early breast cancer and limited lymph node involvement can safely avoid additional axillary surgery.